Últimas noticias sobre Philip Morris Intl (NYSE:PM) Bolsa

PHILIP MORRIS INTERNATIONAL

Philip Morris Intl

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.

Double,Exposure,Image,Of,Coin,Stacks,On,Technology,Financial,Graph

Earnings

News

Pre-Market Outlook

Markets

STLD

TSLA

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este miércoles: PM, STLD, GEV, TSLA y T.

5 acciones en el foco este miércoles: PM, STLD, GEV, TSLA y T

SPDR Dow Jones Industrial Average ETF Trust

GILD

ILMN

NVDA

PYPL

STLA

Las acciones del S&amp;P 500 y Nasdaq caen mientras Nvidia y Tesla sufren pérdidas. Descubre qué está impulsando la volatilidad del mercado.

Acciones en rojo: Nvidia, Tesla y PayPal sufren fuertes caídas en medio de incertidumbre

Short Ideas

Insider Trades

Trading Ideas

Descubre las ventas de insiders en empresas como Lithia, Philip Morris, McDonald&#39;s y Mastercard. ¿Estrategia o preocupación por el mercado?

McDonald&#39;s, Philip Morris y otras 2 acciones que los insiders están vendiendo

Philip Morris International Inc Common Stock

Philip Morris International Inc

Plasmatech Inc

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - April

Innovator U.S. Equity Power Buffer ETF - March

PREMIER INVESTMENTS LTD by Premier Investments Ltd.

Premier Investments Ltd

Powell Max Limited - Class A Ordinary Shares

Powell Max Ltd

Innovator U.S. Equity Power Buffer ETF - May

Pharmala Biotech Holdings Inc

PROMOTORA AMBIENTAL SAB B by Promotora Ambiental SAB de CV

Promotora Ambiental SAB de CV

PEMBINA PPLNE PFD A SER 7 by Pembina Pipeline Corp.

Pembina Pipeline Corp

PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund

PMB AEROSPACE CORP by PMB Aerospace Corporation

PMB Aerospace Corp

PharmaCyte Biotech Inc

PELOTON MINERALS CORP by Peloton Minerals Corporation

Peloton Minerals Corp

PT MERDEKA COPPER GLD TBK by PT MERDEKA COPPER GOLD TBK

PT Merdeka Copper Gold Tbk

Prospector Metals Corp

PROSPECTOR METALS CORP by PROSPECTOR METALS CORP.

Pro Medicus Ltd

Psychemedics Corp.

PSYCHEMEDICS CORP NEW by Psychemedics Corp.

Psychemedics Corp

PRO MEDICUS LTD U/ADR by Pro Medicus, Ltd.

PT MITRA ADIPERKASA TBK by Pt Mitra Adiperkasa Tbk

PT Mitra Adiperkasa Tbk

PT MITRA ADIPERKASA S/ADR by Pt Mitra Adiperkasa Tbk

PACE MEDICAL INC by Pace Medical, Inc.

PLATEAU MINERAL DEV INC by Plateau Mineral Development, Inc.

Plateau Mineral Development Inc

Sonoran Desert Copper Corp

SONORAN DESERT COPPER CP by SONORAN DESERT COPPER CORP

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

PM&E Inc

Primech Holdings Ltd

PREDICTMEDIX AI INC by PREDICTMEDIX AI INC.

Predictmedix AI Inc

PATRIOT BATTERY METALS by PATRIOT BATTERY METALS INC

Patriot Battery Metals Inc

PIMCO Municipal Income Fund

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - February

Priveterra Acquisition Corp II Ordinary Shares - Class A

Priveterra Acquisition Corp II

Priveterra Acquisition Corp II Units (1 Ord Class A & 1/2 War)

Priveterra Acquisition Corp II Warrants (02/12/2025)

Perth Mint Gold Token

Perpetual Energy Inc

PRIME MERIDIAN HLDG CO by Prime Meridian Holding Co.

Prime Meridian Holding Co

PERFECT MED HLTH U/ADR by PERFECT MED HEALTH MGMT LTD.

POLOMAR HEALTH SVCS INC by Polomar Health Services, Inc.

Polomar Health Services Inc

PLASMA INNOVATIVE INC by PLASMA INNOVATIVE INC.

Plasma Innovative Inc

PGIM ETF Trust PGIM Municipal Income Opportunities ETF

PMI GROUP INC NEW by PMI Group, Inc. (The)

PMI Group Inc

PT MULTI INDOCITRA ORD by PT Multi Indocitra Tbk

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - January

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - June

PT MERCK TBK by PT Merck TBK

Playmaker Capital Inc Ordinary Shares

PINKMONKEY.COM INC by PinkMonkey.com, Inc.

PinkMonkey.com Inc

Pimco Municipal Income Fund II Common Shares of Beneficial Interest

PIMCO Municipal Income Fund II

Putnam Managed Municipal Income Trust Common Stock

Putnam Managed Municipal Income Trust

PUMA AG RUDOLF DASSLER SP by Puma AG Rudolf Dassler Sport

Puma SE

PEMBINA PIPELINE CORP PFD by Pembina Pipeline Corp.

Pampa Metals Corp Ordinary Shares

PAMPA METALS CORP by Pampa Metals Corporation

Pampa Metals Corp

PREMIUM EXPL INC by Premium Exploration, Inc.

Premium Exploration Inc

BlackRock ETF Trust iShares Prime Money Market ETF

PREMIUM GROUP CO LTD by PREMIUM GROUP CO LTD.

Premium Group Co Ltd

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - March

Precious Metals and Mining Trust

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - May

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences Inc

Perfect Moment Ltd

PERSEUS MINING LTD ORD by Perseus Mining Ltd

Perseus Mining Ltd

Putnam Municipal Opportunities Trust Common Stock

Putnam Municipal Opportunities Trust

Harbour Energy PLC

Prismo Metals Inc

Polychain Monsters

PRISMONE GROUP INC by PrismOne Group, Inc.

PREMIER PRODUCTS GROUP by Premier Products Group, Inc.

Premier Products Group Inc

Primaris REIT

POP MART INTL UNSP/ADR by Pop Mart International Group Limited

Pop Mart International Group Ltd

PROTEOME SCIENCES PLC by Proteome Sciences PLC

Proteome Sciences PLC

PRIMAL SOLUTIONS INC by Primal Solutions, Inc.

Primal Solutions Inc

PennyMac Mortgage Investment Trust Common Shares of Beneficial Interest

PennyMac Mortgage Investment Trust

PACIFIC METALS CO LTD by Pacific Metals Co., Ltd.

Pacific Metals Co Ltd

PRECIOUS MTLS BULLION TR by Precious Metals Bullion Trust

Perimeter Acquisition Corp I

CPI Card Group Inc

PennyMac Mortgage Investment Trust 8.50% Senior Notes due 2028

PennyMac Mortgage Investment Trust 9.00% Senior Notes due 2030

PLAYMATES TOYS LTD ORD by Playmates Toys Ltd.

Playmates Toys Ltd

PennyMac Mortgage Investment Trust 8.125% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 6.75% Series C Cumulative Redeemable Preferred Shares of Beneficial Interest

PMV CONSUMER ACQ CORP A by PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Corp

PMV CONSUMER ACQ A NEW by PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Corp Warrants (31/08/2027)

PMV Pharmaceuticals Inc

PIMCO Municipal Income Fund III Common Shares of Beneficial Interest

PIMCO Municipal Income Fund III

SYNTARA LTD by SYNTARA LTD.

Primix Corp

Boab Metals Ltd

B of A Securities analyst Lisa Lewandowski maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy and raises the price target from $182 to $200.

Price Target

Analyst Ratings

B of A Securities Maintains Buy on Philip Morris Intl, Raises Price Target to $200

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has outperformed the market over the past 5 years by 5.09% on an annualized basis producing an average annual return of 19.02%. Currently, Philip Morris Intl has a market capitalization of $274.10 billion. 
Buying $1000 In PM: If an investor had bought $1000 of PM stock 5 years ago, it would be worth $2,386.50 today based on a price of $176.10 for PM at the time of writing.
<h3>Philip Morris Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748528119_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

The <a href="https://www.benzinga.com/topic/s-p-500">S&amp;P 500's leaderboard</a> for 2024 features some surprising names and familiar heavyweights. At the top sits NRG Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>), scorching ahead with over 70% gain year-to-date, fueled by a rally in power demand and clean energy transitions. 
Hot on its heels is heavyweight Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), posting a strong 64% YTD surge, making it the only stock from Cathie Wood's ARK Invest universe to crack the S&amp;P 500's top-performing <a href="https://finviz.com/screener.ashx?v=141&amp;f=idx_sp500&amp;o=-perfytd">list</a>.
Other solid performers include Howmet Aerospace Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) (+49% YTD), Philip Morris International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) (+47%) and Uber Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) (+38%), showing strength across energy, industrials, consumer staples, and tech-driven services. Not to be overlooked, General Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) and GE Vernova Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) both shine with gains near 37%, while CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) and VeriSign, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>) round out a diverse group climbing the ranks.
Read Also: <a href="https://www.benzinga.com/general/space/25/05/45584539/donald-trumps-175-billion-golden-dome-could-trigger-a-new-space-arms-race-expert-warns-its-opening-a-pandoras-box">Donald Trump&#8217;s $175 Billion Golden Dome Could Trigger A New Space Arms Race, Expert Warns: &#8216;&#8230;It&#8217;s Opening A Pandora&#8217;s Box&#8217;</a>
Amid this broad mix, Palantir stands out &#8211; not just for its impressive gains but because it's the lone representative from Cathie Wood's innovation-driven ARK funds that's making waves among America's blue-chip giants. After a spectacular 485% surge over the past year, Palantir stock has captured investor attention with its cutting-edge data analytics and government contracts.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0526"><img loading="lazy" decoding="async" width="631" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/26073639/Screenshot-2025-05-26-at-5.06.19-PM.png" alt="" class="wp-image-927473" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/26073639/Screenshot-2025-05-26-at-5.06.19-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/26073639/Screenshot-2025-05-26-at-5.06.19-PM-300x231.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0526">Chart created using Benzinga Pro</a>
Technically, Palantir stock remains bullish, trading above its 20-day, 50-day and 200-day moving averages, classic signs that momentum could continue. The MACD (moving average convergence/divergence) indicator and RSI (relative strength index) indicators also support a bullish signal, suggesting Palantir stock's rally isn't finished yet.
However, Wall Street analysts take a more cautious stance. Recent ratings from New Street Research, Goldman Sachs, and Deutsche Bank average to a price target near $118 &#8211; only marginally above the current $123 price &#8211; implying limited upside for Palantir stock.
For Cathie Wood's ARK funds, Palantir remains the rare success story in the S&amp;P 500 this year, proving that selective innovation still has a place amid the index's top performers.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45603240/trump-agrees-to-extend-50-tariffs-on-europe-until-july-9-it-was-my-privilege-to-do-so">Trump Agrees To Extend 50% Tariffs On Europe Until July 9: &#8216;It Was My Privilege To Do So&#8217;</a></li>
</ul>
Image: Shutterstock/Hiroshi-Mori-Stock

Long Ideas

Tech

PLTR

UBER

VRSN

Palantir: The Only Cathie Wood Pick Among S&P 500's Top Performers

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has outperformed the market over the past 5 years by 4.94% on an annualized basis producing an average annual return of 19.22%. Currently, Philip Morris Intl has a market capitalization of $270.40 billion. 
Buying $1000 In PM: If an investor had bought $1000 of PM stock 5 years ago, it would be worth $2,408.43 today based on a price of $173.72 for PM at the time of writing.
<h3>Philip Morris Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747925118_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Philip Morris Intl 5 Years Ago Would Be Worth This Much Today

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Jefferies analyst Antonio Pedro Cardoso initiated coverage on VTEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) with a Hold rating and announced a price target of $7.3. Vtex shares closed at $6.14 on Wednesday. <a href="https://www.benzinga.com/quote/vtex/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst Gerald Pascarelli initiated coverage on Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with a Hold rating. Altria Group shares closed at $59.45 on Wednesday. <a href="https://www.benzinga.com/quote/mo/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst David Strauss initiated coverage on Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) with an Equal-Weight rating and announced a price target of $13. Intuitive Machines shares closed at $11.23 on Wednesday. <a href="https://www.benzinga.com/quote/lunr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst Gerald Pascarelli initiated coverage on Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy rating and announced a price target of $195. Philip Morris shares closed at $174.64 on Wednesday. <a href="https://www.benzinga.com/quote/pm/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Sebastien Naji initiated coverage on Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) with an Outperform rating. Astera Labs shares closed at $92.17 on Wednesday. <a href="https://www.benzinga.com/quote/alab/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22081330/image-286-1024x576.png" alt="" class="wp-image-924315" style="width:635px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22081330/image-286-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22081330/image-286-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22081330/image-286-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22081330/image-286.png 1142w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/25/05/45540545/jim-cramer-recommends-not-buying-mosaic-doesnt-like-this-industrial-stock"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45540545/jim-cramer-recommends-not-buying-mosaic-doesnt-like-this-industrial-stock">Jim Cramer Recommends Not Buying Mosaic, Doesn&#8217;t Like This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

Initiation

ALAB

LUNR

VTEX

This Philip Morris International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Needham analyst Gerald Pascarelli initiates coverage on Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy rating and announces Price Target of $195.

Needham Initiates Coverage On Philip Morris Intl with Buy Rating, Announces Price Target of $195

Philip Morris Intl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) short percent of float has risen 36.36% since its last report. The company recently reported that it has 13.92 million shares sold short, which is 0.9% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.83 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Philip Morris Intl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747767626_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Philip Morris Intl has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Philip Morris Intl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Philip Morris Intl's peer group average for short interest as a percentage of float is 2.98%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

How Is The Market Feeling About Philip Morris Intl?

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 3.17%</li>
<li>Barclays analyst Gaurav Jain maintained an Overweight rating and raised the price target from $175 to $205 on May 2, 2025. This analyst has an accuracy rate of 65%.</li>
<li>JP Morgan analyst Jared Dinges maintained an Overweight rating and boosted the price target from $145 to $160 on Feb. 18, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: On April 23, Philip Morris reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS guidance above estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest PM <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0519">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0519"><img loading="lazy" decoding="async" width="907" height="828" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032716/image-222.png" alt="" class="wp-image-919364" style="width:619px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032716/image-222.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032716/image-222-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032716/image-222-768x701.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 3.31%</li>
<li>Barclays analyst Lauren Lieberman maintained an Equal-Weight rating and cut the price target from $60 to $57 on May 12, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Morgan Stanley analyst Dara Mohsenian maintained an Equal-Weight rating and cut the price target from $63 to $58 on May 9, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Recent News: On May 8, Molson Coors Beverage reported worse-than-expected first-quarter financial results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest TAP <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0519">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0519"><img loading="lazy" decoding="async" width="907" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032750/image-223.png" alt="" class="wp-image-919365" style="width:596px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032750/image-223.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032750/image-223-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032750/image-223-768x713.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 3.46%</li>
<li>Morgan Stanley analyst Megan Alexander maintained an Equal-Weight rating and cut the price target from $183 to $177 on April 17, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Underweight rating and raised the price target from $125 to $132 on March 14, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On May 1, Hershey posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest HSY <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0519">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0519"><img loading="lazy" decoding="async" width="912" height="821" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032827/image-224.png" alt="" class="wp-image-919366" style="width:706px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032827/image-224.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032827/image-224-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19032827/image-224-768x691.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45466164/jim-cramer-prefers-autozone-over-rival-buy-the-one-thats-not-going-to-stock-split">Jim Cramer Prefers AutoZone Over Rival: &#8216;Buy The One That&#8217;s Not Going To Stock Split&#8217;</a> </li>
</ul>
Photo via Shutterstock

Dividends

Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields

Each week,&nbsp;Benzinga&#8217;s Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/25/05/45171636/exclusive-aprils-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-apple-palantir-nvidia-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: April&#8217;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?</a>
Here's a look at the Benzinga Stock Whisper Index for the week ending May 16:
 Realty Income Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>): The real estate investment trust that pays out monthly dividends saw increased interest from readers during the week. Realty Income reported first-quarter financial results on May 5 and could be seeing interest after the report. The company <a href="https://www.realtyincome.com/investors/press-releases/realty-income-announces-operating-results-three-months-ended-march-31-2025">reported </a>adjusted funds from operations of $1.06, meeting a Wall Street consensus estimate. This came after two straight quarters of missing analyst estimates. The company reported quarterly sales of $1.38, which beat a Street estimate of $1.31 billion. This was the sixth straight quarter of beating analyst sales estimates. The company's CEO Sumit Roy highlighted the company's "high-quality tenant base," and predictable cash flows. The stock saw several analysts<a href="https://www.benzinga.com/quote/O/analyst-ratings"> raise their price targets</a> after the report.
Realty Income stock was up slightly on the week, as shown on the <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516">Benzinga Pro chart </a>below. Shares are up around 2% over the last year.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="997" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182455/Screenshot-416.png" alt="" class="wp-image-918543" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182455/Screenshot-416.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182455/Screenshot-416-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182455/Screenshot-416-768x389.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Simon Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>): Investors were also drawn to another REIT this week with Simon Property Group seeing increased interest after reporting first-quarter financial <a href="https://investors.simon.com/news-releases/news-release-details/simonr-reports-first-quarter-2025-results-and-reaffirms-full">results </a>on May 12. The company missed funds from operations estimates from analysts, but beat sales estimates. The company has beaten analyst estimates for sales in more than 10 straight quarters. Simon Property Group reaffirmed full-year FFO guidance of a range of $12.40 to $12.65. The company also highlighted its US Mall and Premium Outlets occupancy up 0.4% from 95.5% in last year's first quarter to 95.9% in this year's first quarter. The company also saw the opening of Jakarta Premium Outlets in Indonesia in the quarter, with Simon Property owning 50% of the mall. Stifel <a href="https://www.benzinga.com/quote/SPG/analyst-ratings">maintained their Buy rating</a> on the stock and raised the price target from $168.5 to $180.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="997" height="494" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182508/Screenshot-417.png" alt="" class="wp-image-918544" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182508/Screenshot-417.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182508/Screenshot-417-300x149.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182508/Screenshot-417-768x381.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Cheniere Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>): The liquified natural gas company <a href="https://www.benzinga.com/trading-ideas/25/05/45183831/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-63">returns to the index </a>after another strong week of increased interest from readers. The company reported financial results on May 8 and has found its way onto the index two times in the last four weeks. Cheniere Energy missed analyst estimates for earnings per share, which was only the second miss in the last 10 quarters. The company beat sales estimates with $5.44 billion versus an estimate of $4.91 billion. This was the second straight quarter of beating sales estimates and seventh of the last 10 overall. The company reconfirmed some of its full-year financial targets and saw shares trade down slightly on the mixed results.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="997" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182521/Screenshot-418.png" alt="" class="wp-image-918545" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182521/Screenshot-418.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182521/Screenshot-418-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182521/Screenshot-418-768x389.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Amphenol Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>): The connectors and sensors company hit new all-time highs and continues to see strong interest from readers. The company <a href="https://www.benzinga.com/news/earnings/25/04/44950358/amphenol-q1-earnings-48-topline-growth-driven-by-it-mobile-defense-sectors">reported first-quarter financial results</a> in April with earnings per share and revenue both beating analyst estimates. In fact, the company has beaten analyst estimates for both key figures in more than 10 straight quarters. The first quarter saw sales up 48% year-over-year with strong organic growth in the IT market and organic growth in the networks markets. Contributions from recent acquisitions also helped the revenue growth. Guidance from the company for the second quarter came in ahead of analyst estimates for both revenue and earnings per share. Analysts were quick to<a href="https://www.benzinga.com/quote/APH/analyst-ratings"> raise their price targets </a>after the results. The stock was up over 4% in a week that came several weeks after earnings. The stock is up around 30% over the last year and may continue to go higher with strong quarterly results.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="997" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182534/Screenshot-419.png" alt="" class="wp-image-918546" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182534/Screenshot-419.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182534/Screenshot-419-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182534/Screenshot-419-768x386.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Philip Morris International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>): The international tobacco company could be one of the stocks gaining interest from investors as a stock that could be highly insulated from the tariff impacts. The company sells tobacco products in other countries with facilities worldwide. In the United States, the company sells the Zyn nicotine pouches thanks to the acquisition of Swedish Match in 2023. The pouches are made in the United States. Philip Morris' smoke-free product lines have <a href="https://www.benzinga.com/news/earnings/25/04/44949808/zyn-gum-makers-smoke-free-business-revenue-jumps-15-raises-annual-profit-outlook">grown in the United States </a>and overseas. The company has posted five straight double beat quarters with earnings per share and revenue both coming in ahead of estimates. The stock trades near an all-time high and analysts have been <a href="https://www.benzinga.com/quote/PM/analyst-ratings">raising their price targets. </a>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="997" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182550/Screenshot-420.png" alt="" class="wp-image-918547" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182550/Screenshot-420.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182550/Screenshot-420-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16182550/Screenshot-420-768x385.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/25/04/44883576/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-61" target="_blank" rel="noreferrer noopener">April 18</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/04/45029510/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-62" target="_blank" rel="noreferrer noopener">April 25</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45183831/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-63" target="_blank" rel="noreferrer noopener">May 2</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45335286/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-64">May 9</a></li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/04/45112477/exclusive-if-meta-is-forced-to-divest-instagram-whatsapp-or-facebook-43-pick-this-standout" target="_blank" rel="noreferrer noopener">EXCLUSIVE: If Meta Is Forced To Divest Instagram, WhatsApp, Or Facebook, 43% Pick This Standout</a></li>
</ul>

Exclusives

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

As <a href="https://www.forbes.com/sites/javierhasse/2025/04/22/is-america-missing-out-on-the-global-cannabis-boom/">cannabis goes global</a>, some of the world's largest companies are starting to show their hand. One of them is Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), the world's biggest tobacco company by market cap and one of the most deliberate players in the <a href="https://www.benzinga.com/cannabis">cannabis space</a>.
While peers like Altria and British American Tobacco (BAT) have made splashier moves into recreational marijuana markets, PMI has taken a quieter, more clinical approach: targeting medical cannabis, forming R&amp;D alliances and testing products in tightly regulated markets like Canada.
While often overlooked, its cannabis strategy is beginning to take shape, and its latest partnerships suggest this is just the beginning.
<h3 class="wp-block-heading">A Decade In The Making: PMI's Measured Cannabis Timeline</h3>
PMI's interest in cannabis began almost a decade ago. In 2016, it made a strategic investment in Syqe Medical, an Israeli company known for its precision-dose cannabis inhaler. That investment eventually culminated in full acquisition in 2023, marking PMI's first major cannabis takeover.
Fast forward to 2024–2025, and PMI's footprint has expanded through its pharmaceutical and wellness subsidiary, Vectura Fertin Pharma:
<ul class="wp-block-list">
<li>In September 2024, Vectura launched its first cannabis product, the Luo CBD lozenge, distributed via a partnership with Aurora Cannabis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) and its Canadian medical platform.</li>
<li>In January 2025, Vectura Fertin Pharma and Avicanna Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AVCNF#OTC">AVCNF</a>), a cannabinoid-focused biopharma company, announced a medical and scientific collaboration to further research and patient access through Avicanna's <a class="" href="https://www.mymedi.ca/">MyMedi.ca</a> platform.</li>
</ul>
"PMI has consistently shown interest in the medical side of cannabis," said Aaron Grey, managing director at Alliance Global Partners, in a Forbes <a href="https://www.forbes.com/sites/javierhasse/2025/01/19/worlds-largest-tobacco-company-continues-silent-entry-into-cannabis-is-philip-morris-a-medical-marijuana-supporter/">interview</a>. "This seems like a continuation of that strategy."
<h3 class="wp-block-heading">Medical First, Consumer Later?</h3>
PMI's strategy stands in stark contrast to Altria, which invested <a class="" href="https://www.businesswire.com/news/home/20181207005164/en/Altria-to-Make-Growth-Investment-in-Cronos-Group">$1.8 billion in Cronos Group</a>, and BAT, which has a CAD 125 million <a class="" href="https://stratcann.com/news/global-tobacco-giant-ups-investment-in-canadian-cannabis-producer-organigram/">partnership with Organigram</a>. Those moves have largely centered on consumer products or adult-use cannabis.
PMI, by contrast, is avoiding recreational markets for now and focusing on evidence-based, dose-controlled therapeutics that fit within healthcare systems. Its partner Avicanna is a good example: the company works with SickKids Hospital, the University Health Network and was formerly part of Johnson &amp; Johnson's JLABS incubator.
Also read: <a href="https://www.benzinga.com/general/health-care/25/02/43666635/zyn-changed-nicotine-forever-are-cannabis-pouches-the-next-big-thing">Zyn Changed Nicotine Forever &#8211; Are Cannabis Pouches The Next Big Thing?</a>
"This is a multi-decade strategy," Grey said. "Big Tobacco sees usage trends shifting among younger consumers, away from tobacco and alcohol and toward cannabis. PMI is playing the long game."
<h3 class="wp-block-heading">Why Canada?</h3>
PMI's recent activity is centered in Canada, where federal regulations allow for robust medical cannabis distribution and clinical validation.
Its 2024 partnership with Aurora introduced a novel, dissolvable CBD lozenge for patients, manufactured by Vectura's subsidiary Cogent and offered through Aurora's direct-to-patient network.
"The launch will enable us to make a meaningful impact to patients and to validate our product&#8217;s proposition through real-world patient data," said Michael Kunst, CEO of Vectura Fertin Pharma, in a statement.
Meanwhile, the Avicanna partnership helps PMI integrate into Canada's pharmacist-led medical system, aligning with its reputation-driven, regulatory-first approach.
<h3 class="wp-block-heading">Analysts Weigh In: A Cautious But Serious Entry</h3>
Some believe PMI's partnerships could lead to acquisitions, much like the Syqe Medical trajectory.
"This could follow a similar path," Grey said, "depending on how the collaboration performs."
Others urge patience.
"It's way too early to say," said Dan Ahrens, managing director at AdvisorShares. "We've seen limited activity so far and we believe companies like PMI are waiting for broader regulatory clarity, particularly in the U.S."
"The rate and pace of integration will be dictated by the regulatory landscape," Todd Harrison, founder of CB1 Capital, added on Forbes. "But this is yet another proof point of the eventual entry of traditional CPG."
<h3 class="wp-block-heading">The Bottom Line</h3>
Rather than pursuing high-visibility consumer trends, Philip Morris is investing in infrastructure, focusing on product validation and building a presence in the medical cannabis sector.
In doing so, it's laying the foundation for a more permanent role in the global cannabis market, which doesn't rely on flashy branding but on science, patient access, and regulatory credibility.
As the industry matures, PMI's strategy may prove more durable than louder, riskier entries. And if the U.S. eventually legalizes cannabis at the federal level, don't be surprised if Philip Morris is already in position, ready to scale what it has quietly built.
Author&#8217;s note: This article has been updated to properly reflect the relationship between PMI, its subsidiaries and cannabis-related companies.
Now read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cannabis/25/05/45380854/cannabis-sales-are-up-but-jobs-are-down-why-insiders-call-it-a-strategic-reset-for-survival">Cannabis Sales Are Up, But Jobs Are Down: Why Insiders Call It A Strategic Reset For Survival</a></li>
</ul>
Photo: Shutterstock

Biotech

Cannabis

AVCNF

World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has outperformed the market over the past 5 years by 4.87% on an annualized basis producing an average annual return of 18.84%. Currently, Philip Morris Intl has a market capitalization of $265.67 billion. 
Buying $1000 In PM: If an investor had bought $1000 of PM stock 5 years ago, it would be worth $2,433.42 today based on a price of $170.68 for PM at the time of writing.
<h3>Philip Morris Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746453620_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Barclays analyst Gaurav Jain maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight and raises the price target from $175 to $205.

Comments

Philip Morris Intl

Noticias

Últimas noticias sobre Philip Morris Intl (NYSE:PM) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL